Stephen Basil Thomas - 27 Jun 2024 Form 3 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Role
Director
Signature
/s/ Emily Pimblett, Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
27 Jun 2024
Net transactions value
$0
Form type
3
Filing time
27 Jun 2024, 19:01:24 UTC
Next filing
03 Jan 2025

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 - Power of Attorney